Ematologia

Developments in chronic lymphocytic leukaemia

A second Seminar says chronic lymphocytic leukaemia (CLL)—the most common form of leukaemia in Europe and North America—has a variable course, with survival ranging from months to decades.
Approfondisci

 http://www.thelancet.com/journals/lancet/article/PIIS0140673...

The Lancet